Home > Drug Search >
  • Targets: Beta site amyloid precursor protein cleaving enzyme (BACE)
  •   > 
Drug Filter
Category:
chemistry (36) biology (12)
Status:
Approved (7) NDA Filing (1) Phase Ⅲ (5) Phase Ⅱ (14) Phase Ⅰ (19) IND Filing (2)
Clinical Stage:
Pending (5) Active (26) Discontinued (9)
Bio-Type:
Recombinant polypeptide (4) Recombinant hormone (1) Fusion protein (2)
Company:
GlaxoSmithKline (3) GW pharmaceuticals (1) Hanmi (2) Hansoh Pharma (2) Jiangsu Hengrui Medicine (1) ILDONG PHARMACEUTICAL (1) Ipsen (1) Janssen (1) Lilly (3) MedImmune (2) Merck Sharp & Dohme (1) Millennium Pharmaceutical (1) Novo Nordisk (7) Sanofi (3) Teijin Pharma (1) Yuhan Corporation (1) Zydus cadila (2) Genexine (1) Uni-Bio Science Group (1) PhaseBio (1) Shanghai Benemae Pharmaceutical (1) Eastern Biotech (1) Beijing Jingyitaixiang Technology (1) vTv Therapeutics (3) CoMentis (1) Zealand Pharma (2) Transition therapeutics (1) Merrion Pharmaceuticals (1) Changshan Biochemical Pharmaceutical (1) Changshan ConjuChem biological pharmaceutical (1) ConjuChem (1) PegBio (1) Chongqing Fujin Biomedical (1) Dalian Dien Biological Engineering (1) AstraZeneca (4) Betta (1) Chugai (1)
Indication:
Acute myeloid Leukemia (AML) (1) Alzheimer's disease (AD) (3) Chemotherapy-induced nausea and vomiting (1) Chronic myeloid leukemia (CML ) (1) Chronic obstructive pulmonary disease (COPD) (1) Heart failure (1) Multiple sclerosis (MS) (1) Myelodysplastic syndrome (MDS) (1) Obesity (8) Postoperative nausea and vomiting (1) Type 2 diabetes (36) Diabetes (2) Multiple system atrophy (1) Cardiovascular disorders (1)
Country:
US (2) EU (2) CN (1)
Aprv. Year:
2005 (1) 2009 (1) 2013 (1) 2014 (1) 2016 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 3 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top